# Rafael Torres

> Rafael Torres is a Series B investor at GE Ventures backing Health Care. See 4 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [GE Ventures](https://shizune.co/investors/profile/ge-ventures)
- Location: Menlo Park, United States
- Total investments: 4
- Last investment: May 2020
- Lead investor: 0%
- Last updated: Oct 2026
- LinkedIn: http://www.linkedin.com/in/rafaeltorres
- X (Twitter): http://twitter.com/RAThealth

Rafael Torres is a Series B investor at GE Ventures in Menlo Park focused on Health Care and Health Diagnostics. Rafael Torres - Senior Vice President, Business Development and Strategy @ Varian

## Contacts

5 contacts available for Rafael Torres: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/rafael-torres?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Health Diagnostics | 2 | 50% |
| Medical | 1 | 25% |
| Genetics | 1 | 25% |
| Hospital | 1 | 25% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 50% |
| Series C | 1 | 25% |
| Series D | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Arterys | Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions. | $28M | Series C | May 29, 2020 | https://www.arterys.com |
| Arterys | Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions. | $30M | Series B | Nov 15, 2017 | https://www.arterys.com |
| Valence Health | Valence Health delivers patient-centered, data-driven solutions so providers can achieve optimal reward for quality care.VALENCE HEALTH DELIVERS PATIENT-CENTERED, DATA-DRIVEN SOLUTIONS SO PROVIDERS CAN ACHIEVE OPTIMAL REWARD FOR QUALITY CARE.We share your vision: To collect patient data, share information across the organization, and deliversolutions that sustain success.As providers look to achieve optimal reward for quality care, Valence Health brings together the tools, technology, and processes to assess opportunities, measure outcomes and ensure appropriate payment for quality care across various delivery settings within organization. Our patient-focused, data-driven solutions have created competitive advantage for clients since 1996, and we are uniquely qualified to meet the current and future challenges for health care providers.Based in Chicago, Valence is a privately-held company that serves clients nationwide and is committed to strong client partnerships. Our multidisciplinary staff has experience in the clinical, management, operational, and financial challenges of health care organizations – and can efficiently integrate people and processes to improve quality and sustain success. Our core capabilities offer flexibility and scalability in meeting targeted goals or in creating integrated solutions that address complex challenges.The approach to every engagement is collaborative. We work to create patient-centered solutions that complement workflows, and empower physicians and staff to use data and information to improve outcomes. | $15M | Series B | Nov 19, 2014 | http://www.valencehealth.com |
| CardioDx | CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures. | $34.5M | Series D | May 17, 2010 | http://www.cardiodx.com |

4 of 4 investments shown.

## Co-investors
- [Emergent Medical Partners](https://shizune.co/investors/profile/emergent-medical-partners) — VC Fund, 2 deals together
- [North Bridge Venture Partners & Growth Equity](https://shizune.co/investors/profile/north-bridge-venture-partners) — VC Fund, 2 deals together
- [Temasek](https://shizune.co/investors/profile/temasek) — VC Fund, 2 deals together
- [Benslie Investment Group](https://shizune.co/investors/profile/benslie-international-ltd) — VC Fund, 1 deal together
- [DNA Capital](https://shizune.co/investors/profile/dna-capital) — VC Fund, 1 deal together
- [Flare Capital Partners](https://shizune.co/investors/profile/flare-capitalpartners) — VC Fund, 1 deal together

## About GE Ventures

VC Fund · Menlo Park, United States

GE Ventures combines capital, technical, and commercial services. They invest in the healthcare and life sciences, energy and mobility, manufacturing and supply chain, enterprise productivity applications, digital infrastructure, and frontier technologies sectors.

5 contacts available at GE Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Geoff Smith | Manager | https://shizune.co/investors/profile/geoff-smith-6 |
| Jessica Zeaske | Director of Healthcare Investments | https://shizune.co/investors/profile/jessica-zeaske |
| Kennath H. Stewart | Entrepreneur In Residence | https://shizune.co/investors/profile/kennath-h-stewart |
| Pat Patnode | President of Licensing | https://shizune.co/investors/profile/pat-patnode |
| Kiva Allgood | Chief Commercial Development Officer | https://shizune.co/investors/profile/kiva-allgood |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Rafael Torres invest in?

Rafael Torres invests primarily in Health Care, Health Diagnostics and Medical startups, most often at Series B and Series C stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Rafael Torres?

Public channels for Rafael Torres include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Rafael Torres last invest?

The most recent investment recorded for Rafael Torres closed in May 2020. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co